The β2-Adrenoceptor Agonist Terbutaline Specifically Decreases Pulmonary Arterial Pressure By α-Adrenoceptor Antagonism

被引：0
|
作者：
Wenzel, D. [1 ]
Stolle, V. [1 ]
Knies, R. [1 ]
Matthey, M. [1 ]
Welschoff, J. [1 ]
Breuer, J. [1 ]
Fleischmann, B. [1 ]
机构：
[1] Univ Bonn, Bonn, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2270
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The β2 agonist terbutaline specifically decreases pulmonary arterial pressure under normoxia and hypoxia via α adrenoceptor antagonism
    Neumann, Vanessa
    Knies, Ralf
    Seidinger, Alexander
    Simon, Annika
    Lorenz, Kristina
    Matthey, Michaela
    Breuer, Johannes
    Wenzel, Daniela
    FASEB JOURNAL, 2018, 32 (05): : 2519 - 2530
  • [2] The β2-adrenoceptor terbutaline is a strong vasorelaxant of pulmonary arteries
    Wenzel, Daniela
    Matthey, Michaela
    Welschoff, Julia
    Stolle, Vanessa
    Knies, Ralf
    Breuer, Johannes
    Fleischmann, Bernd K.
    FASEB JOURNAL, 2008, 22
  • [3] The β2-adrenoceptor agonist bronchodilators terbutaline and orciprenaline are also weak α1-adrenoceptor antagonists
    Khammy, Makhala M.
    Truong, Cindy Kha Han
    Wright, Christine E.
    Angus, James A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 882
  • [4] The 2-Adrenoceptor Agonist Terbutaline Stimulates Angiogenesis via Akt and ERK Signaling
    Lemmens, Stefanie
    Kusters, Lauren
    Bronckaers, Annelies
    Geurts, Nathalie
    Hendrix, Sven
    JOURNAL OF CELLULAR PHYSIOLOGY, 2017, 232 (02) : 298 - 308
  • [5] Photosensitizing and antioxidant activities of humic substances: A case study of β2-adrenoceptor agonist terbutaline
    Zhou, Lei
    Sleiman, Mohamad
    Halladja, Sabrina
    Ferronato, Corinne
    Chovelon, Jean-Marc
    Richard, Claire
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY, 2020, 391
  • [6] β2-Adrenoceptor agonist activity of higenamine
    Hudzik, Thomas J.
    Patel, Metul
    Brown, Andrew
    DRUG TESTING AND ANALYSIS, 2021, 13 (02) : 261 - 267
  • [7] Antagonism of long-acting β2-adrenoceptor agonism
    Lipworth, BJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (03) : 231 - 245
  • [8] β2-Adrenoceptor agonist profiling reveals biased signalling phenotypes for the β2-adrenoceptor with possible implications for the treatment of asthma
    De Pascali, Francesco
    Ippolito, Michael
    Wolfe, Emily
    Komolov, Konstantin E.
    Hopfinger, Nathan
    Lemenze, Douglas
    Kim, Nicholas
    Armen, Roger S.
    An, Steven S.
    Scott, Charles P.
    Benovic, Jeffrey L.
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (19) : 4692 - 4708
  • [9] The long-acting 2-adrenoceptor agonist olodaterol attenuates pulmonary inflammation
    Wex, Eva
    Kollak, Ines
    Duechs, Matthias J.
    Naline, Emmanuel
    Wollin, Lutz
    Devillier, Philippe
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (14) : 3537 - 3547
  • [10] Pharmacogenetic characterization of indacaterol, a novel β2-adrenoceptor agonist
    Sayers, I.
    Hawley, J.
    Stewart, C. E.
    Billington, C. K.
    Henry, A.
    Leighton-Davies, J. R.
    Charlton, S. J.
    Hall, I. P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (01) : 277 - 286
12345